Firehawk® Stent —— The World's First
and Only TES Receives CFDA Approval
|The stent with the lowest dosage of drug amongst all DES's maintains excellent efficacy with likely lower risk of late thrombosis|
|Targeted unidirectional eluting technology with fully biodegradable polymers generates precisely controlled drug-release kinetics|
|Unique position identification/recognition and state-of-the art 3D printing technologies enables abluminal coating in discrete microgrooves at desirable accuracy with consistency|
|The largest pre-market clinical study following the most stringent protocol in China ensures high credibility of safety and efficacy data|
|Solid evidence-based medical data paves the way for world-wide introduction|
MicroPort and Sorin Sign Joint Venture Agreement
for Cardiac Rhythm Management Business in China
Please see our News section and the Investors section for latest company and industry news made available by MicroPort Scientific Corporation.
Contact Us with any questions or search this site for more information. © Copyright 1998-2014, MicroPort Scientific Corporation. All rights reserved.